Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry
暂无分享,去创建一个
Roberto Ferrari | Gerasimos Filippatos | Andrew J. Coats | Alexandre Mebazaa | Mitja Lainscak | Petar M. Seferovic | G. Filippatos | A. Mebazaa | L. Lund | P. Seferovic | F. Ruschitzka | M. Piepoli | R. Ferrari | C. Fonseca | A. Maggioni | G. Ambrosio | J. Parissis | M. Crespo-Leiro | V. Harjola | A. Coats | Aldo P. Maggioni | Stefan D. Anker | Frank Ruschitzka | O. Chioncel | Candida Fonseca | Ovidiu Chioncel | John Parissis | Cecile Laroche | C. Laroche | Veli-Pekka Harjola | Massimo Francesco Piepoli | Maria G. Crespo-Leiro | Lars Lund | Giuseppe A. Ambrosio | S. Anker | M. Lainščak
[1] J. Tardif,et al. Ivabradine in stable coronary artery disease without clinical heart failure. , 2014, The New England journal of medicine.
[2] C. Lam,et al. The middle child in heart failure: heart failure with mid‐range ejection fraction (40–50%) , 2014, European journal of heart failure.
[3] B. Borlaug,et al. Diastolic and Systolic Heart Failure Are Distinct Phenotypes Within the Heart Failure Spectrum , 2011, Circulation.
[4] Karl Swedberg,et al. Influence of Ejection Fraction on Cardiovascular Outcomes in a Broad Spectrum of Heart Failure Patients , 2005, Circulation.
[5] Juerg Schwitter,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[6] Serguei V. S. Pakhomov,et al. Systolic and diastolic heart failure in the community. , 2006, JAMA.
[7] L. Tavazzi,et al. Multicenter Prospective Observational Study on Acute and Chronic Heart FailureClinical Perspective , 2013 .
[8] A. Branzi,et al. Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long‐term outcome study , 2010, European journal of heart failure.
[9] G. Filippatos,et al. European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF‐LT): 1‐year follow‐up outcomes and differences across regions , 2016, European journal of heart failure.
[10] Luigi Tavazzi,et al. Co‐morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey , 2014, European journal of heart failure.
[11] G. Filippatos,et al. Reframing the association and significance of co‐morbidities in heart failure , 2016, European journal of heart failure.
[12] Piotr Ponikowski,et al. EURObservational Research Programme: regional differences and 1‐year follow‐up results of the Heart Failure Pilot Survey (ESC‐HF Pilot) , 2013, European journal of heart failure.
[13] D. Burkhoff,et al. Is Myocardial Recovery Possible and How Do You Measure It? , 2012, Current Cardiology Reports.
[14] Shannon M. Dunlay,et al. Longitudinal Changes in Ejection Fraction in Heart Failure Patients With Preserved and Reduced Ejection Fraction , 2012, Circulation. Heart failure.
[15] Nancy M Albert,et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. , 2007, Journal of the American College of Cardiology.
[16] G. Filippatos,et al. Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology , 2016, European journal of heart failure.
[17] V. Melenovský,et al. Implications of coronary artery disease in heart failure with preserved ejection fraction. , 2014, Journal of the American College of Cardiology.
[18] M. Vaduganathan,et al. Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review , 2016, European journal of heart failure.
[19] D. Kass,et al. Cardiac Structure and Ventricular–Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County, Minnesota , 2007, Circulation.
[20] R. Ferrari,et al. Heart rate reduction in coronary artery disease and heart failure , 2016, Nature Reviews Cardiology.
[21] P. Ponikowski,et al. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long‐Term Registry , 2013, European journal of heart failure.
[22] Peter C Austin,et al. Outcome of heart failure with preserved ejection fraction in a population-based study. , 2006, The New England journal of medicine.
[23] J. Butler,et al. Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction. , 2016, JAMA cardiology.
[24] Volkmar Falk,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.
[25] J. McMurray,et al. Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta‐analysis report , 2013, European journal of heart failure.
[26] Robert N. Doughty,et al. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. , 2011, European heart journal.
[27] L. Tavazzi,et al. Multicenter Prospective Observational Study on Acute and Chronic Heart Failure: One-Year Follow-up Results of IN-HF (Italian Network on Heart Failure) Outcome Registry , 2013, Circulation. Heart failure.
[28] Toni L. Ripley,et al. Candesartan in heart failure , 2006, Clinical interventions in aging.
[29] Michael Böhm,et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study , 2010, The Lancet.
[30] V. Roger,et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. , 2006, The New England journal of medicine.
[31] Sanjiv J. Shah,et al. Developing therapies for heart failure with preserved ejection fraction: current state and future directions. , 2014, JACC. Heart failure.